DNTH vs MS · rev $6.2M vs P/E 20, $344.27B cap
Dianthus Therapeutics Inc. (DNTH) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
MS does not have a complete income-statement cache yet.
DNTH currently screens at market cap $4.40B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the DNTH and MS stock pages for the full models.
Not investment advice.